# Fullbrook Thorpe Investments

> Fullbrook Thorpe Investments is a VC fund backing AgTech and Rental. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Willington, United Kingdom
- Total investments: 5
- Last investment: Mar 2024
- Lead investor: 20%
- Last updated: Aug 2026
- Website: https://www.fullbrookthorpe.com

Fullbrook Thorpe Investments is a private equity fund that invests both directly and as partners with other private equity businesses. It has formed valuable strategic alliances with several prominent private equity businesses such as LDC, Maven Capital Partners, and Yorkshire Fund Managers, as well as forming links with other family officeinvestors.The company was founded in 2015 and is based in Willington, Derbyshire.

## Contacts

5 contacts available for Fullbrook Thorpe Investments. Shizune tracks 3 team members at Fullbrook Thorpe Investments. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/fullbrook-thorpe-investments?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| AgTech | 1 | 20% |
| Rental | 1 | 20% |
| Agriculture | 1 | 20% |
| Car Sharing | 1 | 20% |
| Health Care | 1 | 20% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 20% |
| Series A | 1 | 20% |
| Series B | 1 | 20% |
| Post-IPO Equity | 1 | 20% |
| Equity Crowdfunding | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 2 | 40% |
| Canada | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Andrew Borkowski | Partner & CEO | 1 | — |
| Andy Leaver | Partner & Chairman | 0 | — |
| Tom Leaver | Partner & Commercial Director | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| HEMPALTA | HEMPALTA is an agricultural technology company focused on innovative hemp processing and product creation. HEMPALTA's products are made from industrial hemp grown sustainably in Southern Alberta and processed using a state-of-the-art HempTrain Advanced Processing Plant at the production facility in the heart of Calgary, Alberta, Canada. Itwas founded in 2022 and its headquarters is located in Calgary, Alberta Canada. |  | Post-IPO Equity | Mar 20, 2024 |  |
| HEMPALTA | HEMPALTA is an agricultural technology company focused on innovative hemp processing and product creation. HEMPALTA's products are made from industrial hemp grown sustainably in Southern Alberta and processed using a state-of-the-art HempTrain Advanced Processing Plant at the production facility in the heart of Calgary, Alberta, Canada. Itwas founded in 2022 and its headquarters is located in Calgary, Alberta Canada. | $1M | Equity Crowdfunding | Nov 03, 2022 |  |
| Karshare | Karshare is a community car-sharing platform. | $4.2M | Seed | Aug 09, 2021 |  |
| Atlantic Healthcare | Atlantic Healthcare plc is a specialist pharmaceutical company, focused on developing and commercializing therapeutics that address unmet patient needs and rare diseases. Our work currently focuses on the gastrointestinal (GI) tract and targets the treatment of GI diseases, which have a debilitating effect on the lives of millions of people.Weown the exclusive worldwide rights to alicaforsen, a pipeline within a drug, with the potential to establish a new class of treatments for Inflammatory Bowel Disease (IBD) and other GI diseases.We also own the worldwide rights to renzapride, a molecule with a unique dual mode of action and the potential to treat a variety of GI motility disorders. | $24M | Series B | Nov 01, 2016 |  |
| Atlantic Healthcare | Atlantic Healthcare plc is a specialist pharmaceutical company, focused on developing and commercializing therapeutics that address unmet patient needs and rare diseases. Our work currently focuses on the gastrointestinal (GI) tract and targets the treatment of GI diseases, which have a debilitating effect on the lives of millions of people.Weown the exclusive worldwide rights to alicaforsen, a pipeline within a drug, with the potential to establish a new class of treatments for Inflammatory Bowel Disease (IBD) and other GI diseases.We also own the worldwide rights to renzapride, a molecule with a unique dual mode of action and the potential to treat a variety of GI motility disorders. | $23.1M | Series A | Jan 01, 2013 |  |

5 of 5 investments shown.

## Co-investors
- [LDC](https://shizune.co/investors/profile/ldc) — VC Fund, 2 deals together
- Salix Pharmaceuticals — VC Fund, 2 deals together
- [Adjuvo](https://shizune.co/investors/profile/adjuvo) — VC Fund, 1 deal together
- Prairie Merchant Corporation — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Fullbrook Thorpe Investments invest in?

Fullbrook Thorpe Investments invests primarily in AgTech, Rental and Agriculture startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Fullbrook Thorpe Investments?

Public channels for Fullbrook Thorpe Investments include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Fullbrook Thorpe Investments?

The team at Fullbrook Thorpe Investments includes Andrew Borkowski (Partner & CEO), Andy Leaver (Partner & Chairman) and Tom Leaver (Partner & Commercial Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co